期刊
ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA
卷 31, 期 1, 页码 117-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.coms.2018.08.006
关键词
Head and neck cancer; Gene therapy; Corrective gene therapy; Cytoreductive gene therapy; Gene editing
资金
- Merck
- Pfizer
Although overall cancer death rates are decreasing, comparative improvements in head and neck squamous cell cancer are modest. Although new advances targeting immune checkpoints may soon improve these numbers, additional research for new therapeutic options is vital. One potential treatment avenue is the use of gene therapy. This article provides insight into some gene therapy targets and varied techniques being evaluated for patients with head and neck cancer. Techniques include corrective gene therapy, cytoreductive gene therapy, and gene editing, in addition to a discussion on gene therapy vectors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据